Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.20    -2.20 (-1.29%)
Bid:
168.00
Ask:
168.80
Spread: 0.80 (0.476%)
Market Cap: £206.41m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Directorate Change

29 Sep 2017 07:02

SThree (STHR) Directorate Change 29-Sep-2017 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 For release at 0700 on 29 September 2017

 

SThree plc

("SThree" or the "Group")

 

Directorate Change

 

SThree, the international specialist STEM staffing business, announces that Steve Quinn, Executive Director and CEO, Americas, will step down from the Board, with effect from 30 September 2017. Steve will remain with the Group to offer strategic advice until he returns to the UK during 2018.

 

Steve originally joined the SThree Board on 1 June 2012, as Chief Operating Officer, before being promoted to CEO, Americas during the latter part of 2013. He has led the team that established the Group's Americas business as one of SThree's fastest growing and built a strong management team in the region. His responsibilities as CEO, Americas, will be assumed by colleagues within the well-established operational management structure now in place in the Americas region and it is not anticipated that a Board level successor will be appointed.

 

Gary Elden, Group CEO commented: "Steve has made an outstanding contribution to the development and success of SThree in his various roles, since originally joining as a recruitment consultant with Progressive in 1997. He was a key driver in the creation of Real's Contract Division in 1999, before expanding the brand internationally and establishing the Real Pharma business, as well as later merging four of the Group's businesses to form the Real Staffing Group. Latterly, under his leadership, our Americas region has become one of our fastest growing and most important. On behalf of everyone at SThree, I would like to thank him for his service and wish him well for the future."

 

- Ends -

 

Enquiries:

 

SThree plc

020 7268 6000

Gary Elden, CEO

 

Sarah Anderson, Deputy Company Secretary/IR Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Kevin Smith/Jos Bieneman

 

 

Notes to editors

 

SThree is a leading international specialist staffing business, providing permanent and contract specialist staff to a diverse client base of over 7,000 clients. From its well-established position as a major player in the Information and Communication Technology ('ICT') sector the Group has broadened the base of its operations to include businesses serving the Banking & Finance, Energy, Engineering and Life Sciences sectors.

 

Since launching its original business, Computer Futures, in 1986, the Group has adopted a multi-brand strategy, establishing new operations to address growth opportunities. SThree brands include Computer Futures, Huxley Associates, Progressive and The Real Staffing Group. The Group has circa 2,600 employees in sixteen countries.

 

SThree plc is quoted on the Official List of the UK Listing Authority under the ticker symbol STHR and also has a US level one ADR facility, symbol SERTY.

 

Important notice

 

Certain statements in this announcement are forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Certain data from the announcement is sourced from unaudited internal management information. Accordingly, undue reliance should not be placed on forward looking statements.


ISIN:GB00B0KM9T71
Category Code:BOA
TIDM:STHR
LEI Code:2138003NEBX5VRP3EX50
Sequence No.:4668
 
End of AnnouncementEQS News Service

614223 29-Sep-2017 

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
5th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20265:25 pmRNSHolding(s) in Company
1st Jun 202612:29 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
26th May 20264:00 pmRNSHolding(s) in Company
26th May 20269:30 amRNSHolding(s) in Company
22nd May 20263:00 pmRNSDirector/PDMR Shareholding
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
12th May 20265:16 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20269:51 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20263:30 pmRNSHolding(s) in Company
29th Apr 202612:20 pmRNSResult of AGM
24th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:35 amRNSHolding(s) in Company
14th Apr 202610:29 amRNSHolding(s) in Company
13th Apr 20264:45 pmRNSDirector/PDMR Shareholding
13th Apr 20263:38 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:14 pmRNSHolding(s) in Company
7th Apr 20269:30 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSTotal Voting Rights
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20262:37 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:37 pmRNSPurchase of shares into the EBT
17th Mar 20269:50 amRNSHolding(s) in Company
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 202611:00 amRNSAnnual Financial Report
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20264:37 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.